drugset / Trial / NCT07013240
Botulinum Toxin Injection After Sternotomies to Improve Scar Aspect and Impact
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Sternotomy scars, which are localized in a high-tension area are often dystrophic, hypertrophic or keloidal, and can be difficult to accept to patients who already endured a heavy intervention with high psychologic impact. The investigators wish to evaluate immediate post-surgical injection of botulinum toxin to improve scar aspect and impact. A randomized, placebo-controlled, split-scar clinical trial will determine the improvement of scar aspects assessed by standardized scores (SBSES, POSAS), patient satisfaction and tolerance.
Timeline
- Start
- 2025-07-05
- Primary completion
- 2027-02-28
- Completion
- 2027-02-28
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 50 iu | Other |
Indications
No indication recorded.